The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines

International Journal of Cancer

Volumn 107, Issue 5, 2003, Pages 729-738

  Park, Seok Woo ^a   Lee, Sang Goo ^a   Song, Sang Hyun ^a   Heo, Dae Seog ^a   Park, Bum Jung ^b   Lee, Dong Wook ^c   Kim, Kwang Hyun ^a   Sung, Myung Whun ^a,d  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2 (COX 2); Head and neck cancer; Nitric oxide (NO); NO synthase (NOS); Prostaglandins (PGs)

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLOOXYGENASE 2; DIBUTYRYL CYCLIC GMP; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL 12 ACETATE 13 MYRISTATE; PROSTAGLANDIN; PROSTAGLANDIN E2;

ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; UPREGULATION; UTERINE CERVIX CANCER;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DACTINOMYCIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S-NITROSO-N-ACETYLPENICILLAMINE; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0242332102     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11498     Document Type: Article

References (53)

1. Chan G, Boyle JO, Yang EK, Zhang F, Sachs PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-4.
2. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park BJ, Heo DS, Kim KH. Increased COX-2 expression in human squamous cell carcinomas of head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 2002;2089-96.
3. DuBois RN, Giardiello FM, Smalley WE. Non-steroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin N Am 1996;25:773-91.
4. Elder DJ, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 1996;56:2273-6.
5. Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 1997;3:1679-83.
6. Giardiello FM, Offerhaus GJ, DuBois RN. The role of non-steroidal anti inflammatory drugs in colorectal cancer prevention. Eur J Cancer 1995;31A:1071-6.
7. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
8. Liu XH, Yao S, Kirschenbaum A, Levine AC. NS398, a selective cyclooxygenase inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 1998;58:4245-9.
9. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Murata H, Hori M. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development. J Clin Gastroenterol 1998;27:S47-52.
10. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H, Hori M. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999;94:451-5.
11. Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E. Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer, Gastroenterology 2001;121:1339-47.
12. Sandstrom R, Gelin J, Lundholm K. The effect of indomethacin on food and water intake, motor activity, and survival in tumour-bearing rats. Eur J Cancer 1990;26:811-4.
13. Lundholm K, Gelin J, Hyltander A, Lonnroth C, Sandstrom R, Svaninger G, Korner U, Gulich M, Karrefors I, Norli B. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994;54:5602-6.
14. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P, Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-4.
15. Habib A, Bernard C, Lebret M, Creminon C, Esposito B, Tedgui A, Maclouf J. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol 1997;158:3845-51.
16. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19:711-21.
17. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutation Res 2001;480/ 481:243-68.
18. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M. Role of NO in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90:587-96.
19. Chung HT, Pae HO. Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001; 262:1075-9.
20. Posadas I, Terencio MC, Guillen I, Ferrandiz ML, Coloma J, Paya M, Alcaraz MJ. Co-regulation between COX-2 and iNOS expression in the time-course of murine inflammation. Naunyn-Schied Arch Pharmacol 2000;361:98-106.
21. Rajnakova A, Moochhala S, Goh PM, Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001;172:177-85.
22. Uotila P, Valve E, Martikainen P, Nevalainen M, Nurmi M, Harkonen P. Increased expression of COX-2 and iNOS in human prostate cancer. Urol Res 2001;29:23-8.
23. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of iNOS and COX-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929-34.
24. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58:334-41.
25. Gavilanes J, Moro MA, Lizasoain I, Lorenzo P, Perez A, Leza JC, Alvarez-Vicent JJ. NOS activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:148-52.
26. Bentz BG, Haines 3rd GK, Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carcinogenesis. Head Neck 2000;22:64-70.
27. Bentz BG, Haines 3rd GK, Hanson DG, Radosevich JA. Endothelial constitutive NOS localization in normal and neoplastic salivary tissue. Head Neck 1998;20:304-9.
28. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994;93:1940-7.
29. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, Stuchin SA, Patel IR, Abramson SB. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231-7.
30. Davidge ST, Baker PN, Laughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 1995;77:274-83.
31. Kanner J, Harel S, Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992;27:46-9.
32. Stadler J, Harbrecht BG, DiSilvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 1993;53:165-72.
33. Tsai AL, Wei C, Kulmacz RJ. Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys 1994;313:367-72.
34. Cahlin C, Gelin J, Delbro D, Lonnroth C, Doi C, Lundholm K. Effect of cyclooxygenase and nitric nxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res 2000;60:1742-49.
35. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective iNOS inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective COX-2 inhibitor. Cancer Res 2002;62:165-70.
36. Chung PS, Rhee CK, Kim KH, Paek W, Chung J, Paiva MB, Eshraghi AA, Castro DJ, Saxton RE. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope 2000;110:1312-16.
37. Ku JL, Kim WH, Lee JH, Park HS, Kim KH, Sung MW, Park JG. Establishment and characterization of human laryngeal squamous cell carcinoma cell lines. Laryngoscope 1999;109:976-82.
38. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL, Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 1989;49:5167-75.
39. Inoue H, Tanabe T, Umesono K. Feedback control of COX-2 expression through PPARr. J Biol Chem 2000;275:28028-32.
40. Zhang Z, Sheng H, Shao J, Beauchamp RD, DuBois RN. Posttranscriptional regulation of COX-2 in rat intestinal epithelial cells. Neoplasia 2000;2:523-30.
41. Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling, Crit Care Med 2000;28(Suppl):N37-52.
42. D'Acquisto F, Maiuri MC, de Cristofaro F, Carnuccio R. NO prevents COX-2 expression by inhibiting NF-kB and NF-IL6 activation. Naunyn-Schied Arch Pharmacol 2001;364:157-65.
43. Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334-50.
44. Gudi T, Casteel DE, Vinson C, Boss GR, Pilz RB. NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation. Oncogene 2000;19:6324-33.
45. Coffery RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD. Epidermal growth factor receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 1997;94:657-62.
46. Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Regulation of COX-2 pathway by HER2 receptor. Oncogene 1999;18:305-14.
47. Han JA, Kim JI, Ongusaga PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW. p53-mediated induction of COX-2 counteracts p53- or genotoxic stree-induced apoptosis. EMBO J 2002;21:5635-44.
48. Slice LW, Bui L, Mak C, Walsh JH. Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPase. Biochem Biophys Res Commun 2000:276:406-10.
49. Emerich DF, Dean RL, Snodgrass P, Lafreniere D, Agostino M, Wiens T. Xiong H, Hasler B, Marsh J, Pink M, Kim BS, Perdomo B, et al. Bradykinin modulation of tumor vasculature: II. Activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors. J Pharmacol Exp Ther 2001;296:632-41.
50. Mestre JR, Chan G, Zhang F, Yang EK, Sackc PG, Boyle JO, Shah JP, Edelstein D, Subbaramaiah K, Dannenberg AJ. Inhibition of cyclooxygenase-2 expression: an approach to preventing head and neck cancer. Ann NY Acad Sci 1999;889:62-71.
51. Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. A Selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res 1999;90:1152-62.
52. Sumitani K, Kamijo R, Toyoshima T, Nakanishi Y, Takizawa K, Hatori M, Nagumo M. Specific inhibition of COX-2 results in inhibition of proliferation of oral cancer cell lines via suppression of PGE2 production. J Oral Pathol Med 2001;30:41-7.
53. Shiotani H, Denda A, Yamamoto K, Kitayama W, Endoh T, Sasaki Y, Tsutsumi N, Sugimura M, Konishi Y. Increased expression of COX-2 protein in 4- nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimensulide. Cancer Res 2001;61:1451-6.